Evidence map›Paper›PMID 37374112›Full record

ReviewLife (Basel, Switzerland)2023

The Importance of the Nephrologist in the Treatment of the Diuretic-Resistant Heart Failure.

Ákos Géza Pethő, Mihály Tapolyai, Maria Browne, Tibor Fülöp, Petronella Orosz, Réka P Szabó

Open access · goldAbstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Ákos Géza PethőDepartment of Internal Medicine and Oncology, Faculty of Medicine, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0001-9776-9841
Mihály TapolyaiDepartment of Nephrology, Szent Margit Kórhaz, 1032 Budapest, Hungary.
Maria BrowneDepartment of Medicine, Division of Nephrology, University of Maryland Medical Center, Baltimore, MD 21201, USA.
Tibor FülöpMedicine Service, Ralph H. Jonson VA Medical Center, Charleston, SC 29401, USA.ORCID 0000-0002-3346-7040
Petronella OroszBethesda Children's Hospital, 1146 Budapest, Hungary.
Réka P SzabóDepartment of Nephrology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.ORCID 0000-0001-5502-1587
University of Debrecen · HUMedical University of South Carolina · USSemmelweis University · HUSzent János Kórház · HUUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure is not only a global problem but also significantly limits the life prospects of these patients. The epidemiology and presentation of heart failure are intensively researched topics in cardiology. The risk factors leading to heart failure are well known; however, the real challenge is to provide effective treatments. A vicious cycle develops in heart failure of all etiologies, sooner or later compromising both cardiac and kidney functions simultaneously. This can explain the repeated hospital admissions due to decompensation and the significantly reduced quality of life. Moreover, diuretic-refractory heart failure represents a distinct challenge due to repeated hospital admissions and increased mortality. In our narrative review, we wanted to draw attention to nephrology treatment options for severe diuretic-resistant heart failure. The incremental value of peritoneal dialysis in severe heart failure and the feasibility of percutaneous peritoneal dialysis catheter insertion have been well known for many years. In contrast, the science and narrative of acute peritoneal dialysis in diuretic-resistant heart failure remains underrepresented. We believe that nephrologists are uniquely positioned to help these patients by providing acute peritoneal dialysis to reduce hospitalization dependency and increase their quality of life.

Indexed as

ascitescardiorenal syndromediuretic resistanceheart failuremortalitynephrologistquality of liferenin–angiotensin–aldosterone systemsodium–glucose cotransporter 2 inhibitor

Identifiers

PMID37374112
PMCPMC10303045
OpenAlexW4379519662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.